UroGen Pharma (URGN) Long-Term Investments (2016 - 2026)
UroGen Pharma (URGN) reported Long-Term Investments of $178,000 for Q2 2026, down 96.2% from $4.63 million a year earlier but up 0.6% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Long-Term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma posted Long-Term Investments of $177,000, down 96.5% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of -37.7% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $5.02 million in FY2024 (+11.6%), $4.5 million in FY2023, $223,000 in FY2022 (-67.0%) and $675,000 in FY2021 (-64.3%).
- Five-year quarterly Long-Term Investments spans a low of $177,000 in Q4 2025 and a high of $10.17 million in Q1 2023.
- Year over year, Long-Term Investments has now declined in each of the last four quarters, with growth averaging 63.0% over the last seven quarters.
- The high point for year-over-year Long-Term Investments in five years was Q1 2025 (growth of 838.5%); the low point was Q2 2024 (a decline of 97.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $177,000 (Q1 2026), $177,000 (Q4 2025) and $380,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 1.56 Bn |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | 178,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 178,000.00 |
| Mar 31, 2026 | 177,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Sep 30, 2025 | 380,000.00 |
| Jun 30, 2025 | 4.63 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 4.64 Mn |
| Jun 30, 2024 | 203,000.00 |
| Mar 31, 2024 | 481,000.00 |
| Dec 31, 2023 | 4.50 Mn |
| Sep 30, 2023 | 6.51 Mn |
| Jun 30, 2023 | 7.97 Mn |
| Mar 31, 2023 | 10.17 Mn |
| Dec 31, 2022 | 223,000.00 |
| Sep 30, 2022 | 223,000.00 |
| Jun 30, 2022 | 673,000.00 |
| Mar 31, 2022 | 674,000.00 |
| Dec 31, 2021 | 675,000.00 |
| Sep 30, 2021 | 4.07 Mn |
API Access
UroGen Pharma Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();